BSECompany UpdateResults30 Jul 2026
Navneet Education Ltd
Dear Sir/Madam,
Please find the attachment herewith News paper Publication
Navneet Education Ltd has published un-audited standalone and consolidated financial results for the quarter ended 30th June, 2026, in various newspapers and on its website.
BSEResult▼ NegativeResults30 Jul 2026
Gillette India Ltd
Gillette India Limited has informed the exchange about the Unaudited Financial Results for the quarter ended June 30, 2026
Gillette India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹78.32 crores, a decrease of 10.6% from the same quarter last year. The company's profit before tax stood at ₹21.402 crores, a decrease of 17.8% from the same quarter last year.
BSEOthersResults30 Jul 2026
Sai Capital Ltd
31st Annual Report of the Company for the Financial Year ended March 31, 2026 together with Notice of Annual General Meeting pursuant to Regulation 34 of the SEBI (Listing Obligations and ....
Sai Capital Ltd has released its 31st Annual Report for the financial year ended March 31, 2026, along with a notice convening the 31st Annual General Meeting scheduled for August 25, 2026. The report and meeting notice are available on the company's website and will be dispatched to shareholders via email.
BSEBoard MeetingResults30 Jul 2026
Archidply Industries Ltd
Archidply Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve un-audited Financial Results ....
Archidply Industries Ltd will hold a Board of Directors meeting on August 7, 2026, to consider and approve un-audited financial results for the quarter ended June 30, 2026. The trading window for trading in securities of the Company will remain closed till 48 hours after the declaration of financial results.
BSEBoard MeetingResults30 Jul 2026
Anlon Healthcare Ltd
We have attached herewith outcome of Board Meeting to consider and approve the Financial Results for the quarter ended June 30, 2026.
Kindly take the same on your record.
Thank you.
Anlon Healthcare Ltd has announced the outcome of its Board Meeting, where the Board considered and approved the unaudited financial results for the quarter ended June 30, 2026, and also authorized the Chairman & Managing Director and/or Whole Time Director to enter into a share swap arrangement with the shareholders of Apiqo Organics Private Limited and Bizotic LifeScience Private Limited.
BSEBoard MeetingResults30 Jul 2026
APM Industries Ltd-$
APM Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
APM Industries Ltd has informed BSE that the meeting of the Board of Directors is scheduled on August 07, 2026, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026.
BSECompany UpdateResults30 Jul 2026
Hypersoft Technologies Ltd
Submission of Compliance Certificate under Reg 74(5) of SEBI(DP) Regulations, 2018
Hypersoft Technologies Ltd submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming the dematerialization of securities for the quarter ended June 30, 2026.
BSECompany Update▲ PositiveResults30 Jul 2026
Gillette India Ltd
Gillette India Limited has informed the exchange about the Press Release for the quarter ended June 30, 2026
Gillette India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with sales up 11% and PAT up 9% compared to the same period last year.
BSECompany UpdateResults30 Jul 2026
Prabhu Steel Industries Ltd
Newspaper Advertisement -Unaudited Financial Result for the quarter ended June 30,2026
Prabhu Steel Industries Ltd has announced unaudited standalone financial results for the quarter ended June 30, 2026, as approved by the Board of Directors on July 29, 2026, and published in newspapers on July 30, 2026.
BSECompany UpdateResults30 Jul 2026
Aimco Pesticides Ltd
Newspaper Publications informing the shareholders regarding the special window for re-lodgement of transfer requests of physical shares.
Aimco Pesticides Ltd has announced a special window for re-lodgement of transfer requests of physical shares that were lodged prior to April 1, 2019 and rejected/returned due to deficiencies in the documents. The company has published a notice in newspapers and made it available on its website. The SEBI circular is also available on the company's website.
BSECompany Update▲ PositiveResults30 Jul 2026
Apcotex Industries Ltd
Please find enclosed Earning Presentation - June 2026 (Q1 - FY 2026-27)
Apcotex Industries Ltd has released its Q1-FY27 earnings presentation, showcasing a 40% year-on-year growth in revenue from operations, driven by higher price realisations despite lower sales volumes. The company delivered its strongest quarterly financial performance with the highest-ever EBITDA, PBT, and PAT in its history. However, export volumes were impacted by geopolitical tensions in West Asia and resulting logistics disruptions.
BSECompany Update▲ PositiveResults30 Jul 2026
Vedanta Power Ltd
Newspaper Publication
Vedanta Power Ltd has published unaudited financial results for the first quarter ended June 30, 2026, with net profit for the period after tax at Rs 140.83 crore, up from Rs 597.73 crore in the same quarter last year.
BSECompany UpdateResults30 Jul 2026
PNGS Reva Diamond Jewellery Ltd
Copies of Unaudited Financial Results published in newspapers - ''Financial Express'' and ''Loksatta'' on July 30, 2026 are enclosed herewith.
PNGS Reva Diamond Jewellery Ltd has published its unaudited financial results for the quarter ended June 30, 2026, in newspapers 'Financial Express' and 'Loksatta' on July 30, 2026.
BSEBoard MeetingResults30 Jul 2026
Gillette India Ltd
Gillette India Limited has informed the exchange about the Outcome of the Board Meeting held on July 30, 2026
Gillette India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹78,302 lakhs and profit before tax at ₹21,402 lakhs.
BSECompany UpdateResults30 Jul 2026
Paradeep Phosphates Ltd
Enclosed extract of statement of unaudited financial results of the Company for the quarter ended June 30, 2026
Paradeep Phosphates Ltd has announced the enclosed extract of statement of unaudited financial results for the quarter ended June 30, 2026, published in Business Line and The Samaja on July 30, 2026. The company's scrip code in BSE is 543530 and its symbol in NSE is PARADEEP.
BSECompany Update▲ PositiveResults30 Jul 2026
eMudhra Ltd
Earnings Presentation on the financial results of the company for the quarter ended June 30, 2026
eMudhra Ltd has announced its Q1 FY2027 financial results, with revenue growth of 27.8% YoY and EBITDA growth of 40.4% YoY. The company's adjusted EBITDA margin improved to 27.5% and adjusted PAT margin to 17.6%. The company's business overview highlights its three lines of business: trust services, enterprise solutions, and services, with a focus on AI trust and governance.
BSECompany UpdateResults30 Jul 2026
JTL Defence Ltd
Investor Presentation for the quarter ended June 30, 2026
JTL Defence Ltd has released its Q1 FY27 earnings presentation, highlighting revenue growth, expansion plans, and operational improvements.
BSECompany UpdateResults30 Jul 2026
eMudhra Ltd
Newspaper Advertisement of the unaudited financial results of the company for the quarter ended June 30, 2026
eMudhra Ltd publishes unaudited financial results for Q1 FY2027, available on its website and in newspapers.
BSEOthersResults30 Jul 2026
Suven Life Sciences Ltd
Annual Report 2025-26 and Notice of 37th Annual General Meeting (AGM) of the Company
Suven Life Sciences Ltd has announced its Annual Report 2025-26 and Notice of 37th Annual General Meeting (AGM) scheduled to be held on August 25, 2026. The report reveals a widened revenue growth, increased R&D investment, and a net loss. The company has completed Phase 3 studies for several molecules, including Masupirdine, Samelisant, and Tenaclidine, and has initiated Phase 2 clinical trials for others.
BSECompany Update▲ PositiveResults30 Jul 2026
Hester Biosciences Ltd
20260730 Q1 FY27 Press Release
Hester Biosciences Ltd announced its unaudited financial results for Q1 FY27, with standalone revenue up 14% and profit up 88%, and consolidated revenue down 8% and profit up 459% due to an exceptional gain from the amendment of the Gates Foundation loan.